Turnover: 179 million EUR (2022)
Country: France
- Family-owned pharmaceutical company based in Lyon, with operations in 70 countries and around 600 employees)
- Emergency medicines (including Anesthesia-Resuscitation, Algology, Infectiology)
- Neurology (treatment of Parkinson's disease)
- Parenteral nutrition (trace elements, vitamins, electrolytes)
- Solutions (urology irrigation, rinsing and injection)
- n°1 in France for injectable solutions in anesthesia-intensive care
- n°1 in France for urology irrigation solutions
- n°1 in France for small-volume infusions (< 20 ml)
News
Healthcare: Aguettant strengthens its position in injectable medicines 28/07/2023
- Lyon-based laboratory Aguettant is investing 31 million euros in its Lyon and Champagne plants to increase capacity for three strategic drugs used in anesthesia-intensive care and cardiology.
- The company has sales of €179 million.
- in Lyon, a new ampoule production line is due to come on stream this autumn.
- Seven new treatments are in preparation at Aguettant.
- The company's production is 100% French.
- 800 employees, including 700 in France.
- The laboratory has a logistics site in Saint-Fons and twelve subsidiaries abroad.
- Aguettant has also rescued Carelide, a producer of flexible bags in the Hauts-de-France region.
> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)
Sector-GPT est la première IA dédiée aux informations sectorielles.